Hit #37

Lion Biosciences was taken private by management paying $1.37/share. Having bought the stock at close to $4/share, I ended up losing 65%! But thankfully I had a very small number of shares, and this loss did not make any difference to the overall portfolio. I am hoping to avoid such routs, but there will always be a few of these nightmares.

While still a hit, this one is more of a hit and run!